Rotala mexicana Cham. et Schltdl.

原著和名: ミヅマツバ科名: ミソハギ科 = Lythraceae採集地: 群馬県 館林市 多々良沼付近 (上野 館林市 多々良沼付近)採集日: 1986/10/10採集者: 萩庭丈壽整理番号: JH024411国立科学博物館整理番号: TNS-VS-97441

Additional file 1: Table S1. of Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study

Gene expression by participant and clinical characteristics from CBCS Phase 3, 2008–2013. Table S2. RNA counts overall and by race and estrogen receptor (ER) status from CBCS Phase 3, 2008–2013. Table S3. Gene expression and risk of recurrence among women with ER+/HER2– breast cancer from CBCS Phase 3, 2008–2013. (DOCX 81 kb

Additional file 1: of Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification

ER and PR expression levels among cases with discordant biomarker status between cores, restricting to cases with negative (<1 %) ER and PR expression. Cases are ordered on the X-axis by case-level positivity status. Individual cores are represented by black crosses, and case-level positivity status is represented by red crosses. (TIF 452 kb

Additional file 1: of A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women

Table S1. Association of the top seven miRNA SNPs from the full analyses with p < 5 × 10−6 in case versus control and case-only subtype analyses. (XLSX 72 kb

Additional file 2: of A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women

Figure S1. BAIAP2 gene expression (from Gene-Tissue Expression project, GTEx) in human tissues [46]. (DOCX 193 kb

Additional file 2: Figure S1. of Frequency of breast cancer subtypes among African American women in the AMBER consortium

Receiver operating characteristic (ROC) curve in 250 HER2-negative luminal cases (A) and 309 luminal cases (B) regardless of HER2 status, using Ki67 expression to identify PAM50-based luminal B cases. A Ki67 threshold of 7.6% among HER2-negative luminal cases (A) and 7.1% among all luminal cases (B) maximized sensitivity and specificity for identifying PAM50-based luminal B tumors. AUC, area under the curve. (DOCX 43 kb

Additional file 1: of Frequency of breast cancer subtypes among African American women in the AMBER consortium

Supplementary methods. (DOCX 15 kb

Additional file 5: Table S2. of Frequency of breast cancer subtypes among African American women in the AMBER consortium

Effect of raising the Ki67 threshold on the performance of the IHC-based luminal classification scheme. (DOCX 12 kb

Additional file 3: Table S1. of Frequency of breast cancer subtypes among African American women in the AMBER consortium

Classification of luminal breast cancer cases using data from medical records in the AMBER consortium. (DOCX 12 kb

Additional file 4: Figure S2. of Frequency of breast cancer subtypes among African American women in the AMBER consortium

Kernel density plots showing the distribution of Ki67 and PR expression (A and B, respectively) in PAM50-defined luminal A (n = 159) and luminal B (n = 91) subtypes. Analyses were restricted to IHC-based HER2-negative tumors. Vertical lines indicate an 8% threshold for Ki67 (A) and a 20% threshold for PR (B). (DOCX 56 kb